These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15030171)

  • 21. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
    Li CG; Cui WY; Wang H
    Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SURI and Kir6.1 subunits of K(ATP)-channels are co-localized in retinal glial (Müller) cells.
    Eaton MJ; Skatchkov SN; Brune A; Biedermann B; Veh RW; Reichenbach A
    Neuroreport; 2002 Jan; 13(1):57-60. PubMed ID: 11924895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel.
    Brochiero E; Wallendorf B; Gagnon D; Laprade R; Lapointe JY
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F289-300. PubMed ID: 11788443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy.
    Zoga V; Kawano T; Liang MY; Bienengraeber M; Weihrauch D; McCallum B; Gemes G; Hogan Q; Sarantopoulos C
    Mol Pain; 2010 Jan; 6():6. PubMed ID: 20102598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
    Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
    J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a novel member of the ATP-sensitive K+ channel subunit family, Kir6.3, in zebrafish.
    Zhang C; Miki T; Shibasaki T; Yokokura M; Saraya A; Seino S
    Physiol Genomics; 2006 Feb; 24(3):290-7. PubMed ID: 16317080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
    Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
    Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the mechanism of metabolic regulation of ATP-sensitive K+ channels containing Kir6.1 and Kir6.2 subunits.
    Farzaneh T; Tinker A
    Cardiovasc Res; 2008 Sep; 79(4):621-31. PubMed ID: 18522960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
    Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
    Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels.
    Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
    Anesthesiology; 2004 Feb; 100(2):338-46. PubMed ID: 14739809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium.
    Curley M; Cairns MT; Friel AM; McMeel OM; Morrison JJ; Smith TJ
    Mol Hum Reprod; 2002 Oct; 8(10):941-5. PubMed ID: 12356945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury.
    Lefer DJ; Nichols CG; Coetzee WA
    Trends Cardiovasc Med; 2009 Feb; 19(2):61-7. PubMed ID: 19577714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability.
    Yang Y; Li S; Konduru AS; Zhang S; Trower TC; Shi W; Cui N; Yu L; Wang Y; Zhu D; Jiang C
    Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1045-54. PubMed ID: 22972803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human oocytes express ATP-sensitive K(+) channels.
    Du Q; Jovanović S; Sukhodub A; Barratt E; Drew E; Whalley KM; Kay V; McLaughlin M; Telfer EE; Barratt CL; Jovanović A
    Hum Reprod; 2010 Nov; 25(11):2774-82. PubMed ID: 20847183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.